Cargando…

Preoperative chemoradiotherapy followed by local excision in clinical T2N0 rectal cancer

PURPOSE: To investigate whether preoperative chemoradiotherapy (PCRT) followed by local excision (LE) is feasible approach in clinical T2N0 rectal cancer patients. MATERIALS AND METHODS: Patients who received PCRT and LE because of clinical T2 rectal cancer within 7 cm from anal verge between Januar...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Young Seob, Yoon, Yong sik, Lim, Seok-Byung, Yu, Chang Sik, Kim, Tae Won, Chang, Heung Moon, Park, Jin-hong, Ahn, Seung Do, Lee, Sang-Wook, Choi, Eun Kyung, Kim, Jin Cheon, Kim, Jong Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Radiation Oncology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066452/
https://www.ncbi.nlm.nih.gov/pubmed/27730804
http://dx.doi.org/10.3857/roj.2016.01872
Descripción
Sumario:PURPOSE: To investigate whether preoperative chemoradiotherapy (PCRT) followed by local excision (LE) is feasible approach in clinical T2N0 rectal cancer patients. MATERIALS AND METHODS: Patients who received PCRT and LE because of clinical T2 rectal cancer within 7 cm from anal verge between January 2006 and June 2014 were retrospectively analyzed. LE was performed in case of a good clinical response after PCRT. Patients’ characteristics, treatment record, tumor recurrence, and treatment-related complications were reviewed at a median follow-up of 49 months. RESULTS: All patients received transanal excision or transanal minimally invasive surgery. Of 34 patients, 19 patients (55.9%) presented pathologic complete response (pCR). The 3-year local recurrence-free survival and disease free-survival were 100.0% and 97.1%, respectively. There was no recurrence among the patients with pCR. Except for 1 case of grade 4 enterovesical fistula, all other late complications were mild and self-limiting. CONCLUSION: PCRT followed by an LE might be feasible as an alternative to total mesorectal excision in good responders with clinical T2N0 distal rectal cancer.